S&P 500
(0.04%) 5 471.43 points
Dow Jones
(0.09%) 39 145 points
Nasdaq
(0.36%) 17 781 points
Oil
(-0.01%) $80.82
Gas
(-3.66%) $2.66
Gold
(-0.80%) $2 312.10
Silver
(0.18%) $28.92
Platinum
(3.49%) $1 020.80
USD/EUR
(0.25%) $0.936
USD/NOK
(0.69%) $10.68
USD/GBP
(0.42%) $0.792
USD/RUB
(-0.27%) $87.25

Обновления в реальном времени для Apexigen, Inc. [APGN]

Биржа: NASDAQ Сектор: Healthcare Промышленность: Biotechnology
Последнее обновление22 авг. 2023 @ 22:59

8.48% $ 0.385

Live Chart Being Loaded With Signals

Commentary (22 авг. 2023 @ 22:59):

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells...

Stats
Объем за сегодня 94 426
Средний объем 262 332
Рыночная капитализация 9.57M
EPS $-0.240 ( Q2 | 2023-08-10 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.225
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0390 (10.13%)
AADI -3.24%
ABCL 1.47%
ABCM 0.04%
ABEO -2.26%
ABIO -3.08%
ABOS 0.70%
ABSI 1.87%
ABUS -2.30%
ABVX -1.50%
ACAD -0.45%
ACER -17.95%
ACET -4.76%
ACGN 1.29%
ACHL 1.59%
ACHV -1.29%
ACIU -0.75%
ACLX 0.57%
ACRV -2.31%
ACST -2.90%
ACXP 2.30%
ADAG 4.64%
ADAP -4.03%
ADGI 0.87%
ADIL 0.24%
ADMA -2.09%
ADPT 0.44%
ADTX -2.38%
ADVM -3.47%
ADXN -1.60%
AEON -2.89%
AEZS -2.49%
AFMD -1.05%
AGEN -1.82%
AGIO -2.24%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 0.55%
AKRO -3.30%
AKTX 1.45%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC 0.69%
ALGS -0.74%
ALKS 0.33%
ALLK -9.36%
ALLO -5.42%
ALLR -0.53%
ALNA 3.16%
ALNY 2.60%
ALPN 0.02%
ALPX 0.00%
ALRN -1.82%
ALT -9.10%
ALVR 2.60%
ALXN 0.00%
ALXO -12.72%
ALZN 5.10%
AMRN -2.24%
AMTI -3.13%
ANAB 1.22%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX 0.87%
ANPC -3.15%
APGE 0.00%
APGN 8.48%
APGNW 30.65%
APLM -2.22%
APLS 0.45%
APLT -3.15%
APM 0.36%
APOP 0.38%
APRE 0.60%
APTO 5.98%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -4.93%
ARDS -14.23%
ARDX 0.33%
ARGX -0.93%
ARNA 0.00%
ARPO -0.90%
ARQT -0.94%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.09%
ARWR -1.00%
ASLN -3.83%
ASMB -5.81%
ASND -1.74%
ATAI -1.85%
ATHA 6.39%
ATHE 0.56%
ATHX -33.50%
ATNF 4.29%
ATOS 2.44%
ATRA -1.79%
ATXI -2.78%
ATXS -0.22%
AUPH -0.54%
AURA 2.79%
AUTL -1.87%
AVBP -1.89%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -3.86%
AVTX -1.25%
AVXL -4.19%
AXLA 0.00%
AXSM -1.08%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 2.50%
BCAB 5.56%
BCDA -2.23%
BCDAW -41.77%
BCEL 0.00%
BCLI 4.36%
BCRX 1.07%
BCTX 8.90%
BCTXW -16.32%
BCYC 0.85%
BDRX -4.62%
BDTX -1.49%
BEAM 1.20%
BFRA -2.91%
BGNE -2.60%
BIOR -5.96%
BIVI 3.65%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -0.78%
BLU 0.03%
BLUE 0.35%
BMEA -11.13%
BMRN 0.07%
BNOX 6.22%
BNTC -0.42%
BNTX -1.60%
BOLD -12.19%
BOLT -0.05%
BPMC -1.14%
BPTH 0.00%
BPTS -13.47%
BRNS 0.00%
BRTX -3.52%
BTAI 23.73%
BTTX 50.67%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 4.24%
CABA 1.17%
CADL -2.12%
CALA 0.00%
CALC -1.77%
CALT -1.59%
CAPR -1.72%
CARA 0.15%
CARM 13.42%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -4.61%
CCCC -5.84%
CCXI 0.00%
CDAK 0.00%
CDIO -2.18%
CDIOW 24.00%
CDMO -2.89%
CDMOP 0.04%
CDT -4.88%
CDTTW -39.60%
CDTX -1.31%
CDXC 1.02%
CDXS 7.93%
CELC -4.21%
CELU -1.98%
CELUW 11.80%
CERC -1.68%
CERE -1.42%
CERO -2.79%
CEROW -21.56%
CFRX -27.95%
CGEM -3.52%
CGEN -3.31%
CGON -1.49%
CGTX -3.43%
CHMA -6.00%
CHRS 1.90%
CINC 0.00%
CING -2.73%
CINGW 34.95%
CKPT -3.35%
CLBS -16.75%
CLDX -1.41%
CLGN 0.34%
CLLS -4.15%
CLNN 0.00%
CLNNW 0.00%
CLRB 6.30%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB -0.98%
CMND 2.06%
CMPI 0.00%
CMPX -1.42%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.48%
CNCE 0.00%
CNSP -35.93%
CNST 0.00%
CNTA -0.28%
CNTB 0.00%
CNTX -7.31%
COCP -2.00%
COEPW 32.45%
COGT -3.61%
CORT 2.86%
COYA 2.43%
CPRX -1.12%
CRBP -3.39%
CRBU -5.72%
CRDF -1.11%
CRGX -0.07%
CRIS -1.72%
CRNX -6.11%
CRSP 0.57%
CRTX 2.63%
CRVO -5.75%
CRVS 1.69%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -3.73%
CTNM -2.21%
CTXR 2.99%
CUE 6.60%
CVAC -5.65%
CVKD -2.85%
CWBR 2.80%
CYAD -12.96%
CYCC 9.09%
CYCCP 5.49%
CYCN -0.24%
CYT -2.27%
CYTK -2.09%
CYTO -1.82%
DARE 4.02%
DAWN -1.31%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 31.17%
DNLI -1.43%
DNTH -10.11%
DOMH 2.43%
DRMA -4.04%
DRMAW -1.25%
DRNA 0.00%
DRTS 3.45%
DRTSW 0.00%
DRUG 0.95%
DSGN -2.72%
DTIL 1.99%
DYAI 12.26%
EARS -1.77%
EDIT -2.32%
EDSA 3.49%
EFTR 6.39%
EFTRW -51.85%
EIGR -9.21%
ELAB -2.84%
ELDN 8.99%
ELEV -6.22%
ELOX -5.38%
ELTX -4.26%
ELVN -4.17%
ELYM 2.23%
ENGN -1.42%
ENGNW 0.00%
ENLV 2.90%
ENOB 1.79%
ENSC 3.23%
ENTA 0.08%
ENTO -2.42%
ENTX 1.60%
ENVB 2.24%
EPIX -2.36%
EPRX -1.15%
EPZM 0.00%
EQ 0.32%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.44%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -3.62%
ETON 1.83%
ETTX 0.00%
EVAX -2.14%
EVGN 4.76%
EVLO 0.00%
EWTX -0.35%
EXAI -1.13%
EXEL -0.02%
EYEG -0.69%
EYEN 1.53%
EYPT 0.42%
FATE -10.48%
FBIO 0.89%
FBIOP -0.37%
FBLG -15.40%
FBRX -0.02%
FDMT -3.41%
FENC -1.31%
FGEN -7.28%
FHTX 6.87%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -1.06%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.44%
FULC -3.51%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.28%
GANX -2.31%
GBIO -3.16%
GBT 0.01%
GDTC 0.50%
GERN -4.63%
GHRS -2.30%
GLMD -5.00%
GLPG -1.97%
GLSI 2.21%
GLTO -2.16%
GLUE -3.17%
GLYC -10.12%
GMAB -0.62%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -3.13%
GNLX 0.00%
GNPX 1.47%
GNTA 3.94%
GOSS -9.80%
GOVX 0.91%
GOVXW -49.04%
GPCR -7.34%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 1.44%
GRTX 5.14%
GTHX 0.23%
GUTS -4.39%
GXGXW 41.67%
GYRE -8.87%
HALO -1.20%
HARP 0.09%
HCWB -3.75%
HEPA -4.09%
HGEN -84.62%
HILS 5.66%
HLVX 0.15%
HOOK 2.33%
HOTH -3.51%
HOWL -1.50%
HRMY 1.94%
HRTX 4.26%
HSTO 0.00%
HUMA 0.71%
HUMAW -0.01%
IBRX -4.13%
ICCC -0.66%
ICPT 0.21%
ICU 19.18%
ICUCW 20.46%
ICVX -0.91%
IDRA -23.04%
IDYA -1.80%
IFRX -1.85%
IGMS -0.51%
IKNA 1.19%
IKT -0.35%
IMAB 2.33%
IMCR -3.02%
IMGN 0.02%
IMGO 0.00%
IMMP 3.23%
IMMX -7.76%
IMNM 0.35%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -0.67%
IMTXW 6.00%
IMUX 1.85%
IMV 0.00%
IMVT -4.80%
INAB -0.01%
INBX 0.73%
INCY -1.35%
INDP 7.80%
INFI -52.38%
INKT -0.01%
INM 1.49%
INMB 1.82%
INO -1.69%
INSM -1.49%
INTS -2.75%
INVA 0.59%
INZY 0.69%
IOBT -10.63%
IONS 0.96%
IOVA -3.43%
IPA -0.49%
IPHA 5.58%
IPSC -2.34%
IRON -1.79%
ISEE 0.38%
ITOS -1.68%
ITRM 1.67%
IVA 6.96%
IVVD -2.48%
JAGX 1.18%
JANX -3.69%
JAZZ -0.90%
JNCE 0.00%
JSPR -5.85%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -5.41%
KDNY 0.22%
KMPH -0.34%
KNSA -2.06%
KNTE -0.38%
KOD -6.52%
KPRX 0.00%
KPTI -5.48%
KRBP -10.00%
KRON 0.58%
KROS -1.06%
KRRO -8.11%
KRTX 0.03%
KRYS -0.52%
KTRA 8.59%
KTTA -6.79%
KTTAW 0.92%
KURA -0.29%
KYMR -2.99%
KYTX -3.69%
KZIA 5.29%
KZR -0.66%
LABP 0.57%
LBPH -1.53%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.98%
LENZ -5.20%
LEXX -1.54%
LEXXW -14.63%
LGND -0.50%
LGNDV 0.00%
LGVN -7.45%
LIAN -8.28%
LIFE 2.70%
LIPO -3.87%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.57%
LPCN -1.86%
LPTX -2.20%
LQDA -0.33%
LRMR -2.13%
LSTA -4.06%
LTRN 0.87%
LUMO -1.32%
LVTX -1.03%
LXEO -4.08%
LXRX -2.35%
LYEL -36.61%
LYRA 1.20%
MACK 0.10%
MBIO -8.92%
MBRX -1.72%
MCRB 2.47%
MDGL -1.30%
MDNA -13.16%
MDWD -0.14%
MDXG -2.58%
MEIP 1.40%
MESO -1.26%
MGNX -2.33%
MGTA -7.74%
MGTX -4.04%
MGX -4.02%
MIRM -0.78%
MIRO 0.59%
MIST 1.15%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX 0.40%
MLYS -7.48%
MNKD 0.29%
MNMD 0.07%
MNOV 2.11%
MNPR -8.52%
MOLN 2.46%
MOR 1.20%
MORF -3.24%
MREO -2.86%
MRKR 2.57%
MRNA -6.16%
MRNS -4.03%
MRSN -2.38%
MRTX -0.17%
MRUS 0.20%
MRVI -1.46%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -0.93%
MYMD 5.65%
NAMS 2.97%
NAMSW -0.21%
NAUT 1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 12.09%
NCNA 0.73%
NERV -0.63%
NEXI 1.84%
NGM -1.28%
NGNE -1.75%
NKGN 10.08%
NKGNW 8.00%
NKTR -4.21%
NKTX -4.24%
NLSP 5.28%
NLSPW 26.67%
NMRA -2.80%
NMTR -42.97%
NOVN -24.84%
NRBO 7.04%
NRIX -2.60%
NRSN -5.12%
NRSNW 0.00%
NRXP -3.72%
NRXPW 18.33%
NRXS 4.82%
NTBL 3.99%
NTEC -12.45%
NTHI 0.00%
NTLA -6.75%
NTRBW -31.07%
NUVL -1.83%
NVAX -2.16%
NVCT 2.82%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.92%
OABIW -10.06%
OBIO -2.92%
OBSV 0.00%
OCEA 0.00%
OCGN 2.12%
OCS -1.00%
OCUL 0.08%
OCUP 1.64%
ODT -4.27%
OKYO 1.51%
OLMA -5.20%
OMER -1.16%
OMGA 5.63%
ONCO 4.04%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY 1.48%
ONTX -0.47%
ONVO 1.31%
OPNT 0.00%
OPT 3.09%
ORGS 0.96%
ORIC -3.49%
ORMP 17.94%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.22%
OVID 1.43%
OYST 0.00%
PALI 1.30%
PASG -1.30%
PBLA -7.50%
PBM -3.48%
PBYI 1.01%
PCSA 0.00%
PCVX -0.22%
PDSB -2.85%
PEPG 1.38%
PGEN -2.40%
PHAR 1.51%
PHAS 0.00%
PHAT -1.40%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.32%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.65%
PLUR 7.39%
PMN 0.72%
PMVP -0.60%
PNT 0.16%
PPBT -6.38%
PRAX 4.83%
PRDS 0.93%
PRLD -2.37%
PROG -3.47%
PROK 0.22%
PRQR -0.66%
PRTA -2.70%
PRTC 0.49%
PRTG 7.02%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -10.46%
PSTX -0.97%
PTCT -0.45%
PTE -0.82%
PTGX -0.73%
PTIXW -48.41%
PULM 2.60%
PXMD 4.76%
PYPD 0.07%
PYXS 0.82%
QLGN -3.00%
QNCX 5.70%
QNRX -1.14%
QSI -11.97%
QSIAW -3.13%
QTTB -3.39%
QURE -0.90%
RAIN -1.63%
RANI 6.42%
RAPT -1.30%
RARE 1.45%
RCKT -8.81%
REGN 0.30%
RENB -3.42%
REPL -1.93%
RETA 0.02%
REUN -0.89%
REVB -2.79%
REVBU 3.46%
REVBW 5.00%
RGLS -6.78%
RGNX -5.84%
RIGL -3.29%
RLAY -3.86%
RLMD 0.35%
RLYB -1.34%
RNA 0.60%
RNAC -2.94%
RNAZ -1.92%
RNXT 0.89%
ROIV -2.17%
ROIVW 4.56%
RPHM -0.62%
RPRX 0.30%
RPTX -0.29%
RUBY 2.70%
RVLP -32.05%
RVMD -1.03%
RVMDW -30.00%
RVNC 0.21%
RVPH -1.98%
RVPHW 1.62%
RXDX 0.09%
RXRX -4.48%
RYTM -5.59%
RYZB 0.02%
RZLT 2.33%
SABS -1.37%
SABSW -11.81%
SAGE 1.19%
SANA -3.51%
SAVA -0.47%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -0.06%
SCPH 4.42%
SCPS 0.00%
SEEL -7.82%
SEER 0.65%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -0.87%
SGMT -2.66%
SGTX -2.56%
SIOX 22.63%
SLDB -8.54%
SLGL 2.91%
SLN -4.41%
SLNO -4.47%
SLRX 5.27%
SLS -1.71%
SMMT -1.12%
SNDX 0.97%
SNGX -4.91%
SNPX -4.39%
SONN 0.00%
SPPI -0.49%
SPRB 0.41%
SPRC -2.75%
SPRO 0.38%
SRNE -34.00%
SRPT -1.12%
SRRA 0.00%
SRRK -2.11%
SRZN -2.45%
STAB 0.00%
STOK -5.48%
STRO -3.13%
STSA 0.00%
STTK -1.69%
SURF -0.93%
SVRA -8.29%
SWTX -0.30%
SYBX -1.29%
SYRS -1.55%
TALS -0.73%
TARA -5.71%
TARS 0.81%
TBPH 0.48%
TCBP 2.48%
TCDA 0.00%
TCON 1.67%
TCRR 0.00%
TCRT 0.08%
TCRX -1.29%
TECH -0.08%
TENX 1.91%
TERN -8.81%
TFFP -5.33%
TGTX -4.43%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -4.60%
TNGX -3.78%
TNXP -6.25%
TNYA -5.06%
TPST 4.86%
TRDA -4.06%
TRVI 2.30%
TRVN 4.02%
TSHA -22.49%
TSVT -2.93%
TTNP -7.66%
TVTX 1.88%
TYRA -8.42%
UBX -2.84%
UNCY -3.84%
URGN -1.15%
UTHR 0.49%
VACC 11.36%
VALN -4.07%
VAXX 116.88%
VBIV 0.73%
VBLT -8.77%
VCEL 0.96%
VCNX 10.35%
VCYT -1.54%
VERA -4.50%
VERU 1.02%
VERV -3.06%
VIGL 4.84%
VINC 2.28%
VIR 0.89%
VIRI -1.73%
VIRX 3.15%
VKTX -1.34%
VLON -13.04%
VNDA -3.18%
VOR -2.41%
VRCA 0.07%
VRDN -4.62%
VRNA -0.47%
VRPX 0.38%
VRTX 0.40%
VSTM -1.33%
VTGN -1.81%
VTVT -2.97%
VTYX -2.09%
VXRT -4.38%
VYGR -0.26%
VYNE -4.62%
VYNT 7.78%
WINT 2.11%
WVE -6.50%
XBIO 1.03%
XBIT -1.88%
XCUR 3.55%
XENE -1.20%
XERS 2.62%
XFOR 4.71%
XLO 3.88%
XLRN 0.00%
XNCR 0.40%
XOMA -3.22%
XOMAO -0.16%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.72%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.83%
ZNTL -2.73%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-08-23 Zabrowksi Dan Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 146 383 Common Stock
2023-08-23 Wertheimer Samuel P Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 12 383 Warrants (right to buy)
2023-08-23 Wertheimer Samuel P Sell 1 845 Warrants (right to buy)
INSIDER POWER
-63.03
Last 97 transactions
Buy: 2 466 920 | Sell: 6 182 886

Объем Корреляция

Длинно: 0.28 (neutral)
Кратко: 0.00 (neutral)
Signal:(44.278) Neutral

Apexigen, Inc. Корреляция

10 Самые положительные корреляции
10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Apexigen, Inc. Корреляция - Валюта/Сырье

The country flag -0.03
( neutral )
The country flag 0.13
( neutral )
The country flag 0.00
( neutral )
The country flag -0.40
( neutral )
The country flag 0.00
( neutral )
The country flag 0.47
( neutral )

Apexigen, Inc. Финансовые показатели

Annual 2022
Выручка: $0
Валовая прибыль: $0 (0.00 %)
EPS: $-1.590
FY 2022
Выручка: $0
Валовая прибыль: $0 (0.00 %)
EPS: $-1.590
FY 2021
Выручка: $0.00
Валовая прибыль: $0.00 (0.00 %)
EPS: $-0.931
FY 2020
Выручка: $0.00
Валовая прибыль: $0.00 (0.00 %)
EPS: $-3.36

Financial Reports:

No articles found.

Apexigen, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Apexigen, Inc.

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.

О Торговые сигналы

Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.

Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа

Total Execution Time: 2.9884750843048 seconds
Number of API calls: 3
Number of DB calls: 9